Stopping versus continuing renin-angiotensin-system inhibitors after acute kidney injury and adverse clinical outcomes: an observational study from routine care data.

Roemer J Janse Edouard L FuCatherine M ClaseLaurie A TomlinsonBengt LindholmMerel van DiepenFriedo W DekkerJuan Jesús Carrero

Published in: Clinical kidney journal (2022)

Stopping RASi use among survivors of moderate-to-severe AKI was associated with a similar risk of recurrent AKI, but higher risk of the composite of death, MI and stroke.

Keyphrases

acute kidney injury
cardiac surgery
healthcare
atrial fibrillation
palliative care
electronic health record
young adults
quality improvement
clinical practice
high intensity
early onset
big data
medical education
pain management
affordable care act
emergency department
adverse drug
cerebral ischemia
deep learning